Readiness-based sparing (RBS) models, which link spare parts investment to weapon system availability, evolved from supply-oriented models created in the 1960s.

Bryan Kohberger agrees to plead guilty in the Idaho student murders to avoid the death penalty, sparking outrage among victims' families.

Selection of patients for organ-sparing treatment When an organ-sparing treatment is contemplated, accurate tumor staging is essential in order to aid preoperative planning.

Circadian cycling of biological processes is widely conserved across phylogeny. Gerstner and Yin discuss how regulators of circadian rhythms — including clock genes, melatonin and the ...

All offices that have university employees and students engaged in collecting or handling cash and, or cash equivalents should have documented standard operating procedures on file. This form ...

Punjab Police drafts SOP on handling cases pertaining to Armymen, state to notify soon In the case of an arrest for a crime unrelated to their duty, the police must inform the nearest military station ...

Land-cover change from energy development, including solar energy, presents trade-offs for land used for the production of food and the conservation of ecosystems. Solar energy plays a critical role ...

Innovative treatments for non–muscle-invasive bladder cancer emerge, focusing on bladder preservation and improved outcomes with novel therapies and active surveillance strategies.

Learn how to define the scope and purpose of an SOP for a complex process using simple questions and steps, and why they are important for quality, consistency, and compliance.

Objective To determine the early and long-term outcomes of conventional aortic root (ARR) and valve-sparing root replacement (VSRR) using a standard perioperative and operative approach. Methods We ...

Your statement of purpose describes what you do, where you do it and who you do it for. All registered providers must have an accurate, up-to-date statement of purpose. It is a legal requirement (see ...

ASCO 2025, SURE-02, neoadjuvant sacituzumab govitecan + pembrolizumab, response-adapted bladder sparing and adjuvant pembrolizumab, muscle invasive bladder cancer.